Category: News

Focus on Cancer RSS Feed 2014-10-16 09:30:00

Penn's Abramson Cancer Center and the Caring for Carcinoid Foundation are teaming up to provide a free day-long neuroendocrine tumor conference for patients and caregivers.

This free educational conference highlights news in NET diagnosis, disease and symptom management and panel discussion.

Attendees will receive the latest information about research, treatment advances, clinical trials, and survivorship issues.

Who Should Attend?

This session can be helpful for those newly diagnosed, currently in treatment, or who are long-term survivors; as well as family members and caregivers of those affected by:
  • Gastrointestinal tract NETs including:
    • Pancreatic NETs (hereditary or sporadic) 
    • Zollinger-Ellison syndrome (gastrinomas)
    • Insulinomas
    • Alimentary tract NETs (foregut, midgut or hindgut)
    • Functional (carcinoid syndrome)
    • Non-functional
  • Bronchial, thymic and carcinoid in other locations
  • Pheochromocytomas and paragangliomas including hereditary and sporadic forms 
  • Hereditary Ssyndromes associated with neuroendocrine tumors

4th Focus On Neuroendocrine Tumors Conference

Date: Friday, October 24, 2014
Time:  8 am to 2:30 pm
Location: Hilton Hotel, 4200 City Avenue, Philadelphia, PA


RSVP for the Focus on Neuroendocrine Tumor Conference here.

Can’t Make the Conference? 

If you can’t make this year’s conference, you can watch or follow the conference live:

October 24: Focus On Neuroendocrine Tumors Conference

Penn's Abramson Cancer Center and the Caring for Carcinoid Foundation are teaming up to provide a free day-long neuroendocrine tumor conference for patients and caregivers.

This free educational conference highlights news in NET diagnosis, disease and symptom management and panel discussion.

Attendees will receive the latest information about research, treatment advances, clinical trials, and survivorship issues.

Who Should Attend?

This session can be helpful for those newly diagnosed, currently in treatment, or who are long-term survivors; as well as family members and caregivers of those affected by:
  • Gastrointestinal tract NETs including:
    • Pancreatic NETs (hereditary or sporadic) 
    • Zollinger-Ellison syndrome (gastrinomas)
    • Insulinomas
    • Alimentary tract NETs (foregut, midgut or hindgut)
    • Functional (carcinoid syndrome)
    • Non-functional
  • Bronchial, thymic and carcinoid in other locations
  • Pheochromocytomas and paragangliomas including hereditary and sporadic forms 
  • Hereditary Ssyndromes associated with neuroendocrine tumors

4th Focus On Neuroendocrine Tumors Conference

Date: Friday, October 24, 2014
Time:  8 am to 2:30 pm
Location: Hilton Hotel, 4200 City Avenue, Philadelphia, PA


RSVP for the Focus on Neuroendocrine Tumor Conference here.

Can’t Make the Conference? 

If you can’t make this year’s conference, you can watch or follow the conference live:

Targeting the c-Met/FZD8 Axis Eliminates HNCSCs

Cancer stem–like cells (CSC) thought to contribute to head and neck squamous carcinomas (HNSCC) may offer attractive therapeutic targets if a tractable approach can be developed. In this study, we report that silencing c-Met is sufficient to suppres...

MT4-MMP/EGFR Axis Triggers Tumor Growth

MT4-MMP (MMP-17) is a glycosylphosphatidyl inositol–anchored matrix metalloprotease expressed on the surface of cancer cells that promotes tumor growth and metastasis. In this report, we identify MT4-MMP as an important driver of cancer cell prolife...